ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 10 analysts with an average price target of $87.05. This is a potential upside of $16.32 (30%) from yesterday's end of day stock price of $66.96.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 202 price targets and 200 ratings on display. The stock rating distribution of ARWR is 74.19% BUY and 25.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.6% with an average time for these price targets to be met of 385.79 days.

Highest price target for ARWR is $126, Lowest price target is $35, average price target is $87.05.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 08-Sep-2026. First documented stock forecast 07-Feb-2014.

Best performing analysts who are covering ARWR - Arrowhead Pharmaceuticals:

Patrick Trucchio Keay Nakae Joel Beatty Maury Raycroft Edward Tenthoff Alethia Young Luca Issi

Currently out of the existing stock ratings of ARWR, 23 are a BUY (74.19%), 8 are a HOLD (25.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Sep-2026

$108

$41.52 (62.45%)

$17

15 days ago
(08-Sep-2026)

7/8 (87.5%)

$22.89 (26.89%)

120

Buy Since 16-Sep-2020

$115

$48.52 (72.98%)

$115

23 days ago
(31-Aug-2026)

24/29 (82.76%)

$32.61 (39.58%)

539

Buy Since 13-May-2020

$100

$33.52 (50.42%)

$87

23 days ago
(31-Aug-2026)

19/20 (95%)

$17.61 (21.37%)

570

Buy Since 25-Sep-2015

$126

$59.52 (89.53%)

$110

2 months ago
(23-Jul-2026)

31/39 (79.49%)

$39.22 (45.19%)

581

Buy Since 23-Jul-2026

$120

$53.52 (80.51%)

$100

2 months ago
(23-Jul-2026)

3/6 (50%)

$33.22 (38.28%)

71

Show more analysts

Please expand the browser size to see the chart

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 386 days for the stock forecasts to be reached, with an average price target met ratio of 81.6%.

Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?

David Lebowitz

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

David Lebowitz works at BMO and has 4 price targets and 4 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Edward Tenthoff with the highest potential upside of $59.52

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

David Lebowitz with the lowest potential downside of -$61.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?